Hypermethylation Test Guides Lynch Syndrome Care: Megan Hoenig, M.S., M.P.H., CGC - Insights
Megan Hoenig, M.S., M.P.H., CGC, explains how Mayo Clinic Laboratories' unique hypermethylation analysis (Mayo ID: MLHPB) provides critical adjunct information for managing Lynch syndrome. That genetic condition increases the risk for many...
Genetic Tests Identify Risk of Fluoropyrimidine-Induced Toxicity: Ann Moyer, M.D., Ph.D. - Insights
Ann Moyer, M.D., Ph.D., explains how Mayo Clinic Laboratories' unique genetic tests identify patients at high risk of severe reactions to fluoropyrimidines — a type of chemotherapy drug. Test results can guide clinical decision-making for...
Assay identifies rare tick-borne bacteria: Bobbi Pritt, M.D. - Insights
Bobbi Pritt, M.D., explains how Mayo Clinic Laboratories' new assay identifies less-common tick-borne bacteria in whole blood. The assay is recommended when tick-borne bacterial infection is suspected but standard testing is unrevealing.
Sounak Gupta, M.B.B.S., Ph.D., explains how Mayo Clinic Laboratories' gynecological NGS panels provide focused assessments of gynecological cancers. The cost-effective tests fill the gap between single gene assays and large cancer panels,...
Robert Jenkins, M.D., Ph.D., Stephanie Smoley, CG(ASCP), and Beth Pitel, M.S., explain how Mayo Clinic Laboratories' enhanced MayoComplete Solid Tumor Panel better profiles tumor genetics. Defining tumor pathogenesis can guide targeted...
Mayo Clinic Laboratory and Pathology Research Roundup: Sept. 24 - Insights
This week’s Research Roundup highlights the limitations of platform assays to measure serum 25OHD level impact on guidelines and practice decision-making.
Leveraging the Laboratory: Seize Tomorrow - Insights
Mayo Clinic Laboratories’ Outreach Conference will be held Sept. 17–18, 2024, in Rochester, Minnesota. “Leveraging the Laboratory: Seize Tomorrow” will provide innovative views into all aspects of health system laboratory outreach programs.
Operational updates - Insights
The latest operational updates from Mayo Clinic Laboratories, including holiday shipping schedules, information technology changes, and more.
Building an effective supply provision program - Insights
Having an efficient and effective supply provision program is a cornerstone for laboratory outreach program success. By providing adequate specimen collection supplies in compliance with current regulations, the outreach laboratory-customer...
This featured section focuses on events, updates, and items of interest for Mayo Clinic Laboratories’ clients, health care providers, lab staff, and the public.
Mayo Clinic Laboratory and Pathology Research Roundup: Sept. 18 - Insights
This week’s Research Roundup highlights Mayo Clinic researchers who conducted a study to characterize the clinical, pathologic, and survival implications of non-V600 BRAF mutations in metastatic colorectal cancer.
Mayo Clinic Laboratory and Pathology Research Roundup: Oct. 16 - Insights
This week’s Research Roundup highlights the role of deficient DNA mismatch repair status in patients with stage III colon cancer treated with FOLFOX adjuvant chemotherapy.
People Archives - Page 35 of 35 - Insights
Skip to Content MayoACCESS MayoLINK...
Leveraging the Laboratory: Seize Tomorrow - Insights
Mayo Clinic Laboratories’ Outreach Conference will be held Sept. 17–18, 2024, in Rochester, Minnesota. “Leveraging the Laboratory: Seize Tomorrow” will provide innovative views into all aspects of health system laboratory outreach programs.
Leveraging the Laboratory: Seize Tomorrow - Insights
Mayo Clinic Laboratories’ Outreach Conference will be held Sept. 17–18, 2024, in Rochester, Minnesota. “Leveraging the Laboratory: Seize Tomorrow” will provide innovative views into all aspects of health system laboratory outreach programs.
Leveraging the Laboratory: Seize Tomorrow - Insights
Mayo Clinic Laboratories’ Outreach Conference will be held Sept. 17–18, 2024, in Rochester, Minnesota. “Leveraging the Laboratory: Seize Tomorrow” will provide innovative views into all aspects of health system laboratory outreach programs.
Leveraging the Laboratory: Seize Tomorrow - Insights
Mayo Clinic Laboratories’ Outreach Conference will be held Sept. 17–18, 2024, in Rochester, Minnesota. “Leveraging the Laboratory: Seize Tomorrow” will provide innovative views into all aspects of health system laboratory outreach programs.
Leveraging the Laboratory: Seize Tomorrow - Insights
Mayo Clinic Laboratories’ Outreach Conference will be held Sept. 17–18, 2024, in Rochester, Minnesota. “Leveraging the Laboratory: Seize Tomorrow” will provide innovative views into all aspects of health system laboratory outreach programs.
Leveraging the Laboratory: Seize Tomorrow - Insights
Mayo Clinic Laboratories’ Outreach Conference will be held Sept. 17–18, 2024, in Rochester, Minnesota. “Leveraging the Laboratory: Seize Tomorrow” will provide innovative views into all aspects of health system laboratory outreach programs.
Leveraging the Laboratory: Seize Tomorrow - Insights
Mayo Clinic Laboratories’ Outreach Conference will be held Sept. 17–18, 2024, in Rochester, Minnesota. “Leveraging the Laboratory: Seize Tomorrow” will provide innovative views into all aspects of health system laboratory outreach programs.
Leveraging the Laboratory: Seize Tomorrow - Insights
Mayo Clinic Laboratories’ Outreach Conference will be held Sept. 17–18, 2024, in Rochester, Minnesota. “Leveraging the Laboratory: Seize Tomorrow” will provide innovative views into all aspects of health system laboratory outreach programs.
According to Mayo Clinic research published in JAMA, six genes contain mutations that may be passed down in families, substantially increasing a person’s risk for pancreatic cancer.
Mayo Clinic Laboratory and Pathology Research Roundup: June 25 - Insights
This week’s Research Roundup highlights the association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer.
Mayo Clinic Laboratory and Pathology Research Roundup: Aug. 21 - Insights
This week’s Research Roundup highlights how intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation.
Mayo Clinic Discovers Biological Markers That Could Guide Treatment for Prostate Cancer - Insights
Genetic alterations in low-risk prostate cancer diagnosed by needle biopsy can identify men that harbor higher-risk cancer in their prostate glands, Mayo Clinic has discovered.
Perspectives Archives - Page 5 of 9 - Insights
Skip to Content MayoACCESS MayoLINK...
Bobbi Pritt, M.D., Advises How to Remove a Tick Quickly and Correctly - Insights
Bobbi Pritt, M.D., Director of the Clinical Parasitology Laboratory and Co-Director of Vector-Borne Diseases Lab Services in Mayo Clinic’s Department of Laboratory Medicine and Pathology, advises how to remove a tick quickly and correctly.
Research Archives - Page 32 of 33 - Insights
Skip to Content MayoACCESS MayoLINK...
Research Archives - Page 31 of 33 - Insights
Skip to Content MayoACCESS MayoLINK...
Mayo Clinic researchers have found that an experimental drug, LCL161, stimulates the immune system, leading to tumor shrinkage in patients affected by multiple myeloma. The findings are published in Nature Medicine.
Mayo Clinic Laboratory and Pathology Research Roundup: December 12 - Insights
This week's research roundup feature: Most patients with solitary bone plasmacytomas (SBP) progress to multiple myeloma (MM) after definitive radiation therapy as their primary treatment. Whether the presence of high-risk (HR) cytogenetic...
Perspectives Archives - Page 6 of 9 - Insights
Skip to Content MayoACCESS MayoLINK...
People Archives - Page 34 of 35 - Insights
Skip to Content MayoACCESS MayoLINK...
Uptick in Vector-Borne Illnesses in U.S. and What It Means to You - Insights
Illnesses caused by disease-infected ticks, mosquitoes, and fleas have tripled in the U.S. in recent years, according to a new report from the Centers for Disease Control and Prevention. Lyme disease is the most common illness attributed to...
CPT codes and LOINC update: November 2021 - Insights
The following list includes updates posted to mayocliniclabs.com during the month of November.
What's Next in Precision Medicine: Moving New Discoveries into Daily Clinical Care - Insights
Experts in individualized medicine—the concept of shaping health care based on lifestyle, environment, and genetic code—will be in Rochester September 12–13 to present how the newest discoveries can be applied to personalized health care.
Mayo Clinic released a new DNA product with Helix, a personal genomics company, called "Mayo Clinic GeneGuide." The DNA-powered product provides healthy individuals with genetic testing and insights with a focus on education.
Week in Review: October 11 - Insights
Top highlights include: Discussions around flu season, teen vaping, spotting signs of cognitive impairment, and DNA tests.
Mayo Clinic Laboratory and Pathology Research Roundup: Nov. 13 - Insights
This week’s Research Roundup highlights how the DnaJ heat shock protein family B member 9 is a novel biomarker for fibrillary GN.
Mayo Clinic Research Advances Diagnostics to Lead COVID-19 Pandemic Response - Insights
When COVID-19 spread across the U.S. in early March, Mayo Clinic’s Advanced Diagnostic Laboratory urgently responded.
Serologic testing for celiac disease in patients with IgA deficiency - Insights
In this month’s “Hot Topic,” Julia Lehman, M.D., discusses serologic testing for Celiac Disease in patients with IgA deficiency.
Mayo Clinic Researchers Find New Way to Improve Newborn Screening of Pompe Disease - Insights
Researchers at Mayo Clinic have discovered a second-tier test for Pompe disease that has been shown to improve the specificity of newborn screening for the disorder, which would lower the rate of false-positive results.
Mayo Clinic Laboratory and Pathology Research Roundup: July 31 - Insights
This week’s Research Roundup highlights urinary extracellular vesicles of podocyte origin and renal injury in preeclampsia.
Mayo Clinic Laboratory and Pathology Research Roundup: July 10 - Insights
This week’s Research Roundup highlights the association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery.
Mayo Clinic Laboratory and Pathology Research Roundup: June 5 - Insights
This week’s Research Roundup highlights oncologic outcomes for patients with residual cancer at cystectomy following neoadjuvant chemotherapy.
Mayo Clinic Laboratory and Pathology Research Roundup: June 19 - Insights
This week’s Research Roundup highlights the single-nephron glomerular filtration rate in healthy adults.
Researchers at Mayo Clinic have identified a possible cause for a rare infection in heart and lung transplant recipients: the donor.
Mayo Clinic Laboratory and Pathology Research Roundup: July 17 - Insights
This week’s Research Roundup highlights postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease.
Mayo Clinic Laboratory and pathology research roundup: August 16 - Insights
This week's research roundup features: Identification of caveolae-associated protein 4 autoantibodies as a biomarker of immune-mediated rippling muscle disease in adults.
Mayo Clinic Laboratory and Pathology Research Roundup: July 23 - Insights
This week’s Research Roundup highlights gastrointestinal and extra-intestinal manifestations of immunoglobulin G4-related disease.